Glaxosmithkline Plc (GSK)
$43.49
0.06 (0.14%)
GSK Stock Quote Delayed 15 Minutes
Previous Close
$43.49
Market Cap
107.84B
PE Ratio
104.54
EPS
0.416
Volume (Avg. Vol.)
3.54M
Day's Range
43.48 - 43.79
52-Week Range
38.43 - 48.25
Dividend & Yield
2.14 (4.92%)
GSK Stock Predictions, Articles, and Glaxosmithkline Plc News
Amarin Has the Makings for a Gamechanging Product
Amarin is targeting a huge market, and its main drug -- Vascepa -- is likely to be expanded in its coverage. Here’s a look at what’s ahead for the stock.
GlaxoSmithKline (GSK) Stock Pops on Pfizer Joint Venture
GlaxoSmithKline (GSK) stock is up today on news of a new joint venture with Pfizer (PFE) for a consumer healthcare business.
3 Big Stock Charts for Tuesday: Morgan Stanley, Ross Stores and Dominion Energy
The stock charts of ROST, D and MS are shaping up as the top trading prospects as December's action gets going.
TSRO, GSK: Tesaro Stock Skyrockets on GlaxoSmithKline Deal
Tesaro stock was flying high on Monday with news that GlaxoSmithKline (GSK) is planning to acquire it in a deal worth $5.10 billion.
GlaxoSmithKline Is More Than Just a 5% Dividend Income Play
GlaxoSmithKline pays shareholders a solid dividend yet the company is not just for income investors. In the next few years, growth in the consumer unit will lead to strong cash flow, raising the chances of dividend hikes for GSK stock.
FDA Shame List: 40 Drug Makers That Try to Block Generic Drugs
The Food and Drug Administration (FDA) announced a list of drug makers that have tried to block generic drugs in its new shame list. Here they are.
GlaxoSmithKline plc Shares Sink on Q1 Earnings Miss
GlaxoSmithKline (GSK) stock was down on Wednesday following the release of an earnings report that misses estimates for the first quarter of 2018.
Navellier Ratings
Powered by Portfolio GraderTotal Grade
B
